Literature DB >> 18001650

[Prevalence of diabetic polyneuropathy in a rural population. Application of the Toronto Clinical Scoring System (TCSS)].

José L del Burgo Fernández, Antonio L Ruiz Serrano, Isabel Maestre Moyano, Inmaculada Cuenca de Yarto, Sara Sánchez García, María G Ballesteros Taboada, Agustina García-Pliego González-Mohíno, Sagrario Gutiérrez Pérez, Lorenzo J Rodríguez Martín, Miguel Loro Rodríguez.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 18001650      PMCID： PMC7664779          DOI： 10.1157/13112204

Source DB:  PubMed          Journal:  Aten Primaria        ISSN： 0212-6567            Impact factor:   1.137


× No keyword cloud information.
  4 in total

1.  Validation of the Toronto Clinical Scoring System for diabetic polyneuropathy.

Authors:  Vera Bril; Bruce A Perkins
Journal:  Diabetes Care       Date:  2002-11       Impact factor: 19.112

2.  Type 1 diabetes mellitus in Catalonia: chronic complications and metabolic control ten years after onset.

Authors:  Ana Cantón; Miquel Fernández Castańer; Ignacio Conget; Gemma Carreras; Conxa Castell; Ricard Tresserras
Journal:  Med Sci Monit       Date:  2004-04-28

3.  The prevalence of clinical diabetic polyneuropathy in Spain: a study in primary care and hospital clinic groups. Neuropathy Spanish Study Group of the Spanish Diabetes Society (SDS).

Authors:  J Cabezas-Cerrato
Journal:  Diabetologia       Date:  1998-11       Impact factor: 10.122

4.  A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population.

Authors:  M J Young; A J Boulton; A F MacLeod; D R Williams; P H Sonksen
Journal:  Diabetologia       Date:  1993-02       Impact factor: 10.122
  4 in total
  1 in total

1.  Manual Acupuncture or Combination with Vitamin B to Treat Diabetic Peripheral Neuropathy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Hai Lun Jiang; Peng Jia; Yi Hua Fan; Meng Dan Li; Can Can Cao; Yuan Li; Yu Zheng Du
Journal:  Biomed Res Int       Date:  2020-11-21       Impact factor: 3.411
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.